Advertisement

Topics

Search Results for "Reminder Sample Letter Prostate Cancer"

09:58 EDT 27th May 2017 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

Male cancer awareness

Cancer of the prostate is the most common cancer in men. The risk of prostate cancer increases with age and is quite rare in men under 50. One in eight men will get prostate cancer at some point in th...

Biomarker could lead to personalised therapies for prostate cancer

In 2016, more than 181,000 new cases of prostate cancer were reported in the U.S., according to the American Cancer Society. The prostate-specific antigen (PSA) test is one of the earliest ways clini...

Prostate cancer: ‘The prostate’ in patients with metastatic prostate cancer: to treat or not to treat?

Advances in understanding of prostate cancer biology and improved treatment options have changed management of metastatic prostate cancer. Escape of the malignancy from the prostatic capsule no longer...

Are men with a family history of prostate cancer eligible for active surveillance?

(Wiley) Active surveillance -- careful monitoring to determine if or when a cancer warrants treatment -- is an increasingly prevalent choice for prostate cancer, but it's unclear if the strategy is ap...

New radiotracer could make diagnosing prostate cancer faster and easier

A new radiotracer has been developed to diagnose prostate cancer. Prostate cancer is the fifth leading cause of death worldwide and is especially difficult to diagnose. While prostate cancer is relati...

Precision Medicine Approach Could Revive Prostate Cancer Test

A new study led by researchers at UC San Francisco and Kaiser Permanente has identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to impro...

Research helps explain why androgen-deprivation therapy doesn't work for many prostate cancers

Metastatic prostate cancer, or prostate cancer that has spread to other organs, is incurable. In new research published in the journal Science, Roswell Park Cancer Institute scientists have identified...

Mark of malignancy identified in prostate cancer

Prostate cancer is the second deadliest cancer in men in the U.S. It kills more than 26,000 men in the country every year. But, as in the case of breast cancer, one prostate cancer will progress rapid...

Matching PubMed Articles

Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.

Intraductal carcinoma of the prostate (IDC-P) is a distinct histopathologic feature associated with high-grade, advanced prostate cancer. Although studies have shown that IDC-P is a predictor of progr...

A Survey of the Knowledge of African-American Women About Prostate Cancer Screening.

Prostate cancer is the second most common cancer diagnosed in men. Its incident and mortality rates are generally higher in populations of African descent. The scientific community recommends that men...

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Protective effects have been suggested for digoxin against prostate cancer risk. However, few studies have evaluated the possible effects on prostate cancer-specific survival. We studied the associati...

Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies.

Prostate Cancer 3 (PCA3) is a long non-coding RNA (ncRNA) upregulated in prostate cancer (PCa). We recently identified a short ncRNA expressed from intron 1 of PCA3. Here we test the ability of this n...

Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.

Although the prognosis of localised prostate cancer is good, the negative effects of prostate cancer treatment often impair patient quality of life. A growing number of men experience these negative e...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement